Pioneering polio surgeon Jacquelin Perry dies

(AP)—Dr. Jacquelin Perry, a world-renowned orthopedic surgeon who pioneered treatments to help polio patients regain movement, has died at age 94 in California.

Perry died Monday at her Downey home. Her death was announced by Rancho Los Amigos National Rehabilitation Center in Downey, where she worked for nearly 60 years.

In the 1950s, Perry developed to help paralyzed polio patients regain some movement. Decades later, some returned with post-polio symptoms of pain and . Perry became an expert into their conditions.

Perry also was known as an expert in the human gait. Her research into helping people with walking difficulties led to practices that are still used.

The Los Angeles Times (lat.ms/16w1ZPV ) reports she had Parkinson's disease but still was treating patients shortly before her death.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

WSU study expands time window for facial nerve rehabilitation

May 10, 2011

SPOKANE, WASH. –A research study conducted at Washington State University Spokane offers hope to those suffering from facial nerve damage. According to the study, which was published online this week in the journal Developmental Ne ...

Texas board mulls stem cell therapy used on Perry

Nov 04, 2011

(AP) -- The experimental stem cell procedure that Texas Gov. Rick Perry underwent this summer could be restricted or even blocked under new rules being considered Friday by the state's Medical Board.

Recommended for you

Cambodia bans 'virgin surgery' adverts

19 hours ago

The Cambodian government has ordered a hospital to stop advertising so-called virginity restoration procedures, saying it harms the "morality" of society.

What's happening with your donated specimen?

Jan 28, 2015

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care?

Amgen tops Street 4Q forecasts

Jan 27, 2015

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.